BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21809361)

  • 1. The Australia antigen and role of the late Philadelphia General Hospital in reducing post-transfusion hepatitis and sequelae.
    Senior JR; London WT; Sutnick AI
    Hepatology; 2011 Sep; 54(3):753-6. PubMed ID: 21809361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum transaminases: correlation with post-transfusion hepatitis].
    De Battisti C; Carulli N; Barbieri E; Gallo M
    Acta Vitaminol Enzymol; 1968; 22(3):85-9. PubMed ID: 5756731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 4. Ways of post-transfusion hepatitis prevention.
    Pintera J
    Czech Med; 1989; 12(3):149-57. PubMed ID: 2509173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis--the state of the art.
    Clowdus BF
    Med Trial Tech Q; 1974; 21(1):63-75. PubMed ID: 4138562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis B and blood transmission (transfusion hepatitis or hospital hepatitis?)].
    Busch H; Eisenhart-Rothe B; Sasse UK
    Infusionstherapie (1973); 1974 Dec; 1(8):633-43. PubMed ID: 4465320
    [No Abstract]   [Full Text] [Related]  

  • 7. A historical perspective on the discovery and elucidation of the hepatitis B virus.
    Block TM; Alter HJ; London WT; Bray M
    Antiviral Res; 2016 Jul; 131():109-23. PubMed ID: 27107897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors.
    Kliman A; Reid NR; Lilly C; Morrison J
    N Engl J Med; 1971 Sep; 285(14):783-5. PubMed ID: 5567264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of transmission of infectious hepatitis by blood preparations through screening of GOT in blood donors].
    Novák J; Urbánková J
    Cas Lek Cesk; 1969 Jun; 108(24):734-7. PubMed ID: 5783179
    [No Abstract]   [Full Text] [Related]  

  • 10. [New possibilities in the prevention of transfusion hepatitis].
    Bergmann H
    Wien Med Wochenschr; 1970 Jun; 120(25):449-53. PubMed ID: 4931839
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated post-transfusion serum transaminase values associated with a highly significant trend for increasing prevalence of anti-Vesivirus antibody in Korean patients.
    Lee H; Cho YH; Park JS; Kim EC; Smith AW; Ko G
    J Med Virol; 2012 Dec; 84(12):1943-52. PubMed ID: 23080501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobel Prize to Baruch Blumberg for the discovery of the aetiology of hepatitis B.
    Zetterström R
    Acta Paediatr; 2008 Mar; 97(3):384-7. PubMed ID: 18298788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anicteric post-transfusion hepatitis].
    Mudrić V; Mironicki Z; Dimić E; Hadnadev M; Vuković B; Sesler A
    Med Pregl; 1971; 24(11):497-502. PubMed ID: 5140028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 15. [New viewpoints in the prevention of transfusion-induced serum hepatitis (Au-SH-Antigen)].
    Pesendorfer F; Krassnitzky O
    Wien Klin Wochenschr; 1971 Aug; 83(31):576-8. PubMed ID: 5566294
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-associated hepatitis not due to viral hepatitis type A or B.
    Feinstone SM; Kapikian AZ; Purcell RH; Alter HJ; Holland PV
    N Engl J Med; 1975 Apr; 292(15):767-70. PubMed ID: 163436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest of enzymatic determinations: OCT, GOT, GPT and observations of the presence of Australia antigen relating to viral hepatitis in blood donors.
    Otto-Servais M; Plomteux G; Brocteur J; Buret J; Lennes G; Andre A; Heusghem C
    Vox Sang; 1970; 19(3):338-44. PubMed ID: 5502764
    [No Abstract]   [Full Text] [Related]  

  • 18. Carriers of hepatitis B antigen and transfusion hepatitis in Finland.
    Helske T
    Scand J Haematol Suppl; 1974; 22():1-65. PubMed ID: 4533828
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the incidence of transfusion hepatitis with special regard to postoperative enzyme increases. A prospective study].
    Wahls E; Arndt-Hanser A; von Lutzki H; Rathgen GH; Bolte JP; Fassl H; Mohammedian N; Lieser H
    Anaesthesist; 1972 Jan; 21(1):12-22. PubMed ID: 5016514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.